More intriguingly, a series of menin small molecule inhibitors (MIs) (such as MI-503, M−525, MI-136, or MI-2) have been reported and used to delve into the multifaceted role of menin across diverse cancer indications in recent years.13 Here, MEN1 is linked to cancer.